425 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma
Condition: Epithelial Ovarian Carcinoma
Interventions: Biological: DCVAC/OvCa;   Drug: Standard of Care (Paclitaxel or topotecan or doxorubicin)
22 Unknown  Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Condition: Ovarian Carcinoma
Intervention: Other: timing of surgery
23 Unknown  Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Other: medical chart review;   Other: study of socioeconomic and demographic variables;   Procedure: disease screening;   Procedure: evaluation of cancer risk factors;   Procedure: genitourinary surgical procedure;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
24 Recruiting Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer
Condition: Ovarian Carcinoma
Intervention: Other: Whole body diffusion-weighted MRI
25 Recruiting Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer;   Peritoneum Tumors
Intervention: Behavioral: Data Collection
26 Not yet recruiting Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Gadofosveset trisodium (Ablavar™ );   Device: MRI
27 Recruiting A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Epithelial Ovarian Cancer
Interventions: Drug: CAELYX;   Drug: Topotecan HCl
28 Unknown  Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
29 Recruiting Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses
Conditions: Ovarian Carcinoma;   Ovarian Cancer;   Ovarian Mass;   Ovarian Cyst
Interventions: Other: Ultrasound by general gynaecologist;   Other: Ultrasound by an expert ultrasonographist;   Other: DW-MRI;   Other: Give blood sample
30 Unknown  IGFBP-3 in Ovarian Cancer Invasion
Condition: Ovarian Carcinoma
Intervention: Procedure: immunohistochemical staining, transfection, invasion assay
31 Unknown  Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Conditions: Epithelial Ovarian Carcinoma;   Figo Stage IIIC
Intervention: Procedure: hyper thermic chemo + surgery
32 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
33 Recruiting EC17 for Intraoperative Imaging in Occult Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: EC17
34 Not yet recruiting Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Recurrent Ovarian Cancer;   Recurrent Endometrial Cancer
Interventions: Drug: BKM120;   Drug: Nabpaclitaxel
35 Recruiting Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer
36 Recruiting A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Rucaparib
37 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
38 Recruiting H.O.P.E: Helping Ovarian Cancer Patients Cope
Conditions: Platinum-resistant Ovarian Cancer;   Recurrent Ovarian Cancer;   Palliative Care
Interventions: Other: Structured Palliative Care;   Other: Usual Care
39 Recruiting Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: FANG™
40 Recruiting Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum
Condition: Ovarian Cancer
Intervention: Drug: carboplatin and liposomal doxorubicin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years